0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Original Investigation | 
Eileen M. Bulger, MD; Ronald V. Maier, MD; Jason Sperry, MD; et al.
JAMA Surg. 2014;149(6):528-536. doi:10.1001/jamasurg.2013.4841.
Includes: CME, Supplemental Content

Invited Critique | 
Martin A. Makary, MD, MPH
Arch Surg. 2007;142(3):284. doi:10.1001/archsurg.142.3.284.

Original Article |  FREE
Amy L. Friedman, MD; Sarah R. Geoghegan, BSN; Noelle M. Sowers, RN; et al.
Arch Surg. 2007;142(3):278-283. doi:10.1001/archsurg.142.3.278.
Includes: CME

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal
From The JAMA Network
JAMA
Viewpoint  | 
Modern Drug Development:  Which Patients Should Come First?
Muthiah Vaduganathan, MD, MPH; Vinay Prasad, MD, MPH
JAMA Internal Medicine
Research Letter  | 
Association of Loop Diuretic Use With Higher Parathyroid Hormone Levels in Patients With Normal Renal Function
Kristin M. Corapi, MD, MMSc; Gearoid M. McMahon, MBBCh; Julia B. Wenger, MPH; et al.
JAMA Pediatrics
Original Investigation  | 
Congenital Anomalies and In Utero Antiretroviral Exposure in Human Immunodeficiency Virus–Exposed Uninfected Infants
Paige L. Williams, PhD; Marilyn J. Crain, MD; Cenk Yildirim, MS; et al.
JAMA Internal Medicine
Viewpoint  | 
Secondary Prevention of Cardiovascular Disease With Vorapaxar:  A New Era of 3-Drug Antiplatelet Therapy?
Mori J. Krantz, MD; Sanjay Kaul, MD